« Previous
Next »
Experimental Hematology
Volume 35, Issue 4
, Pages
534-540
, April 2007
Yttrium-90–ibritumomab tiuxetan (Zevalin) combined with high-dose BEAM chemotherapy and autologous stem cell transplantation for chemo-refractory aggressive non-Hodgkin's lymphoma
To access this article, please choose from the options below
PII: S0301-472X(07)00050-1
doi: 10.1016/j.exphem.2007.01.043
© 2007 International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Experimental Hematology
Volume 35, Issue 4
, Pages
534-540
, April 2007
